Article Content

MarketFlick Insights

Tech Down 6.2% Is Money Rotating into Oil and Pharma?

Monday, October 26, 2026
3 min read
Tech Down 6.2% Is Money Rotating into Oil and Pharma?

At a glance

  • Tech sector fell 6.20% in one month while energy rose 11.2%, consumer staples 7.07% and health care 6.21%.
  • Metas large capex and negative free cash flow triggered concerns about funding AI investments and growth.
  • Declining 10-year Treasury yields did not prevent tech weakness, suggesting the sell-off is tied to business fundamentals and investment risk.
  • Bonds paying near 5% are drawing capital that might otherwise chase long-term AI upside in tech.
  • Near-term market direction depends on the Fed decision and upcoming earnings from Microsoft, Alphabet and Amazon.

Market Analysis

Money is flowing out of U.S. technology stocks and into more defensive and resource-linked sectors. Over the past month the U.S. technology sector has fallen 6.20 percent, while energy climbed 11.2 percent, consumer staples rose 7.07 percent and health care gained 6.21 percent. The catalyst for the shift was Meta Platforms: its third-quarter capital spending exceeded cash generated by the business.

Metas results on October 21 served as a wake-up call. The company disclosed roughly $34.91 billion in spending on data centers and technology versus $32.79 billion in operating cash flow. Free cash flow turned negative for the first time in over a decade, at minus $2.12 billion, and management did not provide a capital expenditure outlook for 2027. Since the announcement the stock has fallen about 7.9 percent, and the communications services segment declined roughly 6.26 percent over the month.

Investors seem to be pricing the pain into big techs AI investments rather than into higher interest rates. Evidence for that view came on October 22, when the yield on the 10-year U.S. Treasury dropped 17 basis points to 4.96 percent, yet technology names still retreated. Bonds remain a competitive alternative: a relatively secure yield near 5 percent reduces the premium investors are willing to pay today for distant AI-driven profits. At the same time, expensive oil is keeping inflation elevated, supporting energy-sector performance.

Defensive and commodity-adjacent sectors have been the clear beneficiaries. The S&P 500 health-care index hit a record high on October 20, underlining investor appetite for both stability and earnings visibility. That said, technology hasnt been written off year-to-date the sector still leads by roughly 31.4 percent.

Technical and Near-Term Catalysts

Metas technical picture shows how far the selling pressure has extended. At around $640, the share price sits above its 200-day moving average of $632.49 but below the 50-day line at $664.79. The stock remains about 18 percent under its 52-week high of $779.82. Initial support is the 200-day average, with a lower support zone near $580. The relative strength index (RSI), a gauge of trading momentum, is near 35 approaching oversold territory. A daily close under the 200-day line would signal a break in the uptrend that began over the summer.

Whether the rotation continues will be decided in the coming week. The Federal Reserves rate decision on October 28 is a key event; that same evening Microsoft and Alphabet report earnings, followed by Amazon on October 29. Those results and any Fed commentary about the path of rates will shape how investors allocate between growth, yield and defensive exposure.

For now, the market narrative is clear: some investors are trading potential long-term gains from AI for nearer-term safety and yield, and they are steering capital toward energy and health-care names that either benefit from higher commodity prices or offer more predictable cash flows. If bond yields fall or major tech names deliver better-than-feared results, the trend could reverse. Until then, expect volatility and sector rotation as market participants reassess risk versus return.

MarketFlick Insights

Get the latest analysis and top articles of the week delivered directly to your inbox.

No spam. Unsubscribe anytime.

Tech Down 6.2% Is Money Rotating into Oil and Pharma? | MarketFlick